Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA LUPIN SUN PHARMA/
LUPIN
 
P/E (TTM) x 41.7 39.8 104.6% View Chart
P/BV x 6.7 5.9 114.4% View Chart
Dividend Yield % 0.7 0.3 291.1%  

Financials

 SUN PHARMA   LUPIN
EQUITY SHARE DATA
    SUN PHARMA
Mar-23
LUPIN
Mar-23
SUN PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,072799 134.2%   
Low Rs790583 135.5%   
Sales per share (Unadj.) Rs182.9365.8 50.0%  
Earnings per share (Unadj.) Rs35.79.8 362.6%  
Cash flow per share (Unadj.) Rs46.229.2 158.3%  
Dividends per share (Unadj.) Rs11.504.00 287.5%  
Avg Dividend yield %1.20.6 213.4%  
Book value per share (Unadj.) Rs233.4270.7 86.2%  
Shares outstanding (eoy) m2,399.34454.98 527.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.11.9 269.4%   
Avg P/E ratio x26.170.2 37.2%  
P/CF ratio (eoy) x20.123.7 85.1%  
Price / Book Value ratio x4.02.6 156.2%  
Dividend payout %32.240.7 79.3%   
Avg Mkt Cap Rs m2,233,361314,381 710.4%   
No. of employees `000NANA-   
Total wages/salary Rs m82,96030,872 268.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m438,857166,417 263.7%  
Other income Rs m8,1991,509 543.3%   
Total revenues Rs m447,055167,926 266.2%   
Gross profit Rs m112,90017,206 656.2%  
Depreciation Rs m25,2948,807 287.2%   
Interest Rs m1,7202,743 62.7%   
Profit before tax Rs m94,0847,165 1,313.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,4762,688 315.3%   
Profit after tax Rs m85,6084,477 1,912.2%  
Gross profit margin %25.710.3 248.8%  
Effective tax rate %9.037.5 24.0%   
Net profit margin %19.52.7 725.1%  
BALANCE SHEET DATA
Current assets Rs m398,619124,513 320.1%   
Current liabilities Rs m199,06492,654 214.8%   
Net working cap to sales %45.519.1 237.5%  
Current ratio x2.01.3 149.0%  
Inventory Days Days14726 560.6%  
Debtors Days Days9598 96.8%  
Net fixed assets Rs m376,960103,490 364.2%   
Share capital Rs m2,399910 263.7%   
"Free" reserves Rs m557,555122,246 456.1%   
Net worth Rs m559,954123,156 454.7%   
Long term debt Rs m0275 0.0%   
Total assets Rs m775,794228,003 340.3%  
Interest coverage x55.73.6 1,542.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.7 77.5%   
Return on assets %11.33.2 355.5%  
Return on equity %15.33.6 420.6%  
Return on capital %17.18.0 213.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m154,05348,057 320.6%   
Fx outflow Rs m71,51121,752 328.8%   
Net fx Rs m82,54126,306 313.8%   
CASH FLOW
From Operations Rs m49,59318,972 261.4%  
From Investments Rs m-79,437-12,868 617.3%  
From Financial Activity Rs m23,761-3,373 -704.5%  
Net Cashflow Rs m1,1552,732 42.3%  

Share Holding

Indian Promoters % 54.5 46.8 116.5%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 36.6 45.8 79.8%  
FIIs % 17.1 16.1 106.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 53.0 86.0%  
Shareholders   612,626 281,542 217.6%  
Pledged promoter(s) holding % 2.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Sun Pharma vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sun Pharma vs Lupin Share Price Performance

Period Sun Pharma Lupin S&P BSE HEALTHCARE
1-Day -0.54% -1.91% -1.19%
1-Month 2.17% -0.31% -5.23%
1-Year 62.60% 144.90% 57.11%
3-Year CAGR 39.27% 16.32% 18.05%
5-Year CAGR 27.20% 15.94% 18.83%

* Compound Annual Growth Rate

Here are more details on the Sun Pharma share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Sun Pharma hold a 54.5% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sun Pharma and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Sun Pharma paid a dividend of Rs 11.5 per share. This amounted to a Dividend Payout ratio of 32.2%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of Sun Pharma, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.